If you have ever opened a bottle of eucalyptus oil and felt that sharp, cooling rush, you have met 1,8-cineole. Also called eucalyptol, it is one of the most studied single compounds in aromatherapy — and, unusually, some of that research involves human trials. So what does the evidence support, and where does the marketing run ahead of it?
How to read the evidence levels on The Oil Owl: A = human clinical data, B = animal (in vivo) studies, C = cell or test-tube (in vitro) studies, D = theoretical.
What Is 1,8-Cineole?
1,8-Cineole is a cyclic monoterpene ether with a fresh, camphor-like aroma. It evaporates readily, which is why it reaches the nose and airways so easily. A review traces its sources, biological activities and uses, noting that it is well absorbed but cleared quickly (PMID 33111547).
Rich sources include Eucalyptus globulus (often 60–85%), cineole-type rosemary, cajuput, niaouli, bay laurel and cardamom. Percentages vary with species, chemotype and distillation; a batch GC/MS report is the only way to know.
How Researchers Think It Works — Evidence Levels B and C
- Inflammatory signalling (C). In cultured human immune cells, 1,8-cineole dampened NF-kB signalling and reduced TNF-alpha, IL-1beta, IL-6 and IL-8 (PMID 32200535).
- Antioxidant pathways (B/C). Preclinical anti-inflammatory and antioxidant effects are often linked to NF-kB suppression and Nrf2 activation (PMID 33111547).
- Antibacterial and anti-biofilm activity (C). A 2025 review summarises laboratory activity against airway-relevant bacteria and biofilms (PMID 39885809).
- Platelets (B/C). In mice and in human platelets in the lab, 1,8-cineole altered platelet activation and thrombus formation (PMID 34685597) — a reason for caution if you take blood-thinning medication.
A compound that calms a pathway in a dish does not automatically do the same, to any meaningful degree, when you inhale a diffused oil.
The Human Evidence — Evidence Level A (oral medicine)
- COPD. In a double-blind, placebo-controlled trial, 242 people with stable COPD took 200 mg cineole capsules three times daily alongside their usual care for six winter months. The cineole group had fewer, shorter and milder exacerbations, with improvements in lung function and quality of life (PMID 19624838).
- Common cold. In an open-label, non-randomized exploratory trial, 329 adults who developed a cold took 200 mg cineole three times daily; those who started earliest had the lowest symptom burden and a shorter time to remission. The study was industry-funded and had no placebo group (PMID 38236839).
- Asthma and COPD overview. A review summarises these and earlier controlled studies of cineole as an add-on to standard care (PMID 32200535).
The catch is the route. These trials tested a registered, standardized oral capsule of purified cineole, taken under medical supervision in addition to conventional care. That is a world away from home aromatherapy. It is not evidence that sniffing eucalyptus oil influences COPD, asthma or a cold. Anyone who cites these trials to sell an inhaler blend is quietly swapping one thing for another.
What About Inhalation? — Evidence Level A (small, multi-ingredient)
- In 12 people with chronic bronchitis, a chest rub of aromatics (a multi-ingredient product) modestly speeded mucus clearance during the first hour only (PMID 12804077).
- Eucalyptol is one of the four standard odours in olfactory training for people recovering their sense of smell after infection (PMID 27017331) — used there as a training stimulus, not as an active treatment.
Much of the "clearer breathing" feeling from eucalyptus may come from cineole's interaction with cold-sensing receptors in the nose. The sensation is real and can feel pleasant; feeling that air moves more freely is not the same as a measured change in lung function.
Safety: A Compound That Deserves Respect
- Never swallow essential oils. The trials used a pharmaceutical capsule precisely because dose and purity were controlled. Swallowed eucalyptus oil can cause serious poisoning, including seizures and severe metabolic acidosis, as documented in two adult case reports (PMID 31685016).
- Children. Eucalyptus oil has been a leading cause of childhood poisoning hospitalisations in one Australian region, most often via vaporisers within reach (PMID 9270157). Keep cineole-rich oils away from the faces of babies and young children and out of reach — see safe essential oils for children.
- Asthma and reactive airways. Strong aromas can irritate rather than soothe. Introduce them cautiously and stop if they bother you.
- Anticoagulants. Treat the platelet findings as a reason to speak with your doctor.
- Skin. Dilute properly — see our dilution guide. In pregnancy, see our pregnancy guide.
If you have a respiratory condition, the single most useful thing this article can say is: talk to your doctor, and do not replace medical treatment with a diffuser.
Using Cineole-Rich Oils Thoughtfully
- A short diffuser session in a well-ventilated room, rather than hours of continuous diffusion.
- A drop on a tissue for brief personal inhalation, away from children.
- Oils with a current GC/MS report, so you know the cineole content.
Current Evidence Summary 1,8-Cineole has genuine human trial data (Evidence Level A) — but for a standardized oral medicine taken alongside medical care (PMID 19624838, PMID 38236839), not for aromatherapy. Anti-inflammatory, antioxidant and antibacterial mechanisms are preclinical (B/C). Inhalation evidence is small and indirect. Ingested eucalyptus oil is a documented poisoning risk, especially for children.
References
- Cai ZM et al. J Asian Nat Prod Res 2021. PMID 33111547
- Juergens LJ et al. Adv Ther 2020. PMID 32200535
- Markowski J, Junka A. Otolaryngol Pol 2025. PMID 39885809
- Alatawi KA et al. Cells 2021. PMID 34685597
- Worth H et al. Respir Res 2009. PMID 19624838
- Michalsen A et al. PLoS One 2024. PMID 38236839
- Hasani A et al. J Altern Complement Med 2003. PMID 12804077
- Konstantinidis I et al. Rhinology 2016. PMID 27017331
- Ittyachen AM et al. J Med Case Rep 2019. PMID 31685016
- Day LM et al. Aust N Z J Public Health 1997. PMID 9270157
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Essential oils are not a substitute for medical treatment, and they must never be swallowed. Unless stated otherwise, the mechanisms discussed come from preclinical research (cell and animal studies). Always consult a qualified healthcare professional before using essential oils for health purposes, especially if you are pregnant, nursing, have a medical condition or take medications.